Related references
Note: Only part of the references are listed.Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents
Aline N. Silva da Gama et al.
CURRENT PHARMACEUTICAL DESIGN (2021)
COVID-19 and mutations a threat level assessment
Jared Robinson et al.
NEPAL JOURNAL OF EPIDEMIOLOGY (2021)
Fake Science: XMRV, COVID-19, and the Toxic Legacy of Dr. Judy Mikovits
Stuart J. D. Neil et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2020)
Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold
Matteo Staderini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity
Jurica Levatic et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents
Gautam Kumar et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Syntheses and antibacterial activity of soluble 9-bromo substituted indolizinoquinoline-5,12-dione derivatives
Hui Yang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani
Md Yousuf et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Molecular evolution of the enzymes involved in the sphingolipid metabolism of Leishmania: selection pressure in relation to functional divergence and conservation
Vineetha Mandlik et al.
BMC EVOLUTIONARY BIOLOGY (2014)
An Introduction to the Structural Organization of Parasitic Protozoa
Wanderley Souza
CURRENT PHARMACEUTICAL DESIGN (2008)
The targets of currently used antibacterial agents: Lessons for drug discovery
Roland P. Lange et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Share Paper
